Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for myeloperoxidase reduction in type 2 diabetes
ACTRN12612000734864Phase 4Active, not recruiting
- Sponsor
- Nita Cristina
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fenofibrate in type 2 diabetes mellitus (T2DM), sponsored by Nita Cristina. Primary endpoint: Plasma myeloperoxidase concentration. Started May 2012; status: active, not recruiting.
02
Drugs
fenofibrate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12612000734864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000734864.